• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amrize Ltd filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8/6/25 4:17:14 PM ET
    $AMRZ
    Building Materials
    Industrials
    Get the next $AMRZ alert in real time by email
    amrize-20250806
    FALSE000203598900020359892025-08-062025-08-06

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________________
    FORM 8-K
    ___________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934

    August 6, 2025
    Date of Report (date of earliest event reported)
    ___________________________________
    Amrize Ltd
    (Exact name of registrant as specified in its charter)
    ___________________________________

    Switzerland
    (State or other jurisdiction of
    incorporation or organization)
    1-42542
    (Commission File Number)
    98-1807904
    (I.R.S. Employer Identification Number)
    Grafenauweg 8,
    Zug 6300
    (Address of principal executive offices and zip code)
    +41 41 562 3490
    (Registrant's telephone number, including area code)
    ___________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol
    Name of each exchange on which registered
    Ordinary Shares, par value $0.01 per shareAMRZNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.






    Item 2.02 - Results of Operations and Financial Condition

    On August 6, 2025, Amrize Ltd (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 2.02 in its entirety. A copy of the press release will also be available on the Company’s website.

    Item 7.01 – Regulation FD Disclosure

    To supplement the information in the attached press release, the Company has also prepared an investor presentation, which will be available on the Company’s website at investors.amrize.com/. A copy of the investor presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01 in its entirety.

    The information in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

    Item 9.01 - Financial Statements and Exhibits
    (d): The following exhibits are being filed herewith:

    Exhibit No.Description
    99.1
    Press release dated August 6, 2025
    99.2
    Investor presentation dated August 6, 2025
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document)

    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


    Amrize Ltd
    By:
    /s/ Ian Johnston
    Name:
    Ian Johnston
    Title:
    Chief Financial Officer
    Date:August 6, 2025

    Get the next $AMRZ alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMRZ

    DatePrice TargetRatingAnalyst
    9/9/2025$62.00Outperform
    Oppenheimer
    7/15/2025$57.00Overweight
    Analyst
    7/10/2025$62.00Outperform
    Bernstein
    7/1/2025$57.00Neutral
    Goldman
    6/30/2025Buy
    Erste Group
    6/30/2025$52.50Hold
    Jefferies
    6/30/2025$64.00Buy
    Berenberg
    6/26/2025$56.00Neutral
    BofA Securities
    More analyst ratings

    $AMRZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Brouwer Roald bought $103,760 worth of Ordinary Shares (2,000 units at $51.88), increasing direct ownership by 67% to 5,000 units (SEC Form 4)

    4 - Amrize Ltd (0002035989) (Issuer)

    8/27/25 11:21:12 AM ET
    $AMRZ
    Building Materials
    Industrials

    President, Building Materials Hill Jaime bought $24,792 worth of Ordinary Shares (500 units at $49.59), increasing direct ownership by 4% to 14,101 units (SEC Form 4)

    4 - Amrize Ltd (0002035989) (Issuer)

    8/25/25 4:54:32 PM ET
    $AMRZ
    Building Materials
    Industrials

    President, Building Materials Hill Jaime bought $207,980 worth of Ordinary Shares (4,000 units at $51.99), increasing direct ownership by 42% to 13,601 units (SEC Form 4)

    4 - Amrize Ltd (0002035989) (Issuer)

    8/18/25 1:44:54 PM ET
    $AMRZ
    Building Materials
    Industrials

    $AMRZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oppenheimer initiated coverage on Amrize with a new price target

    Oppenheimer initiated coverage of Amrize with a rating of Outperform and set a new price target of $62.00

    9/9/25 7:42:34 AM ET
    $AMRZ
    Building Materials
    Industrials

    Analyst initiated coverage on Amrize with a new price target

    Analyst initiated coverage of Amrize with a rating of Overweight and set a new price target of $57.00

    7/15/25 8:39:49 AM ET
    $AMRZ
    Building Materials
    Industrials

    Bernstein initiated coverage on Amrize with a new price target

    Bernstein initiated coverage of Amrize with a rating of Outperform and set a new price target of $62.00

    7/10/25 8:50:08 AM ET
    $AMRZ
    Building Materials
    Industrials

    $AMRZ
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Amrize Ltd

    SCHEDULE 13G - Amrize Ltd (0002035989) (Subject)

    8/11/25 8:17:12 AM ET
    $AMRZ
    Building Materials
    Industrials

    SEC Form 10-Q filed by Amrize Ltd

    10-Q - Amrize Ltd (0002035989) (Filer)

    8/7/25 5:05:18 PM ET
    $AMRZ
    Building Materials
    Industrials

    Amrize Ltd filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Amrize Ltd (0002035989) (Filer)

    8/6/25 4:17:14 PM ET
    $AMRZ
    Building Materials
    Industrials

    $AMRZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Brouwer Roald bought $103,760 worth of Ordinary Shares (2,000 units at $51.88), increasing direct ownership by 67% to 5,000 units (SEC Form 4)

    4 - Amrize Ltd (0002035989) (Issuer)

    8/27/25 11:21:12 AM ET
    $AMRZ
    Building Materials
    Industrials

    President, Building Materials Hill Jaime bought $24,792 worth of Ordinary Shares (500 units at $49.59), increasing direct ownership by 4% to 14,101 units (SEC Form 4)

    4 - Amrize Ltd (0002035989) (Issuer)

    8/25/25 4:54:32 PM ET
    $AMRZ
    Building Materials
    Industrials

    President, Building Materials Hill Jaime bought $207,980 worth of Ordinary Shares (4,000 units at $51.99), increasing direct ownership by 42% to 13,601 units (SEC Form 4)

    4 - Amrize Ltd (0002035989) (Issuer)

    8/18/25 1:44:54 PM ET
    $AMRZ
    Building Materials
    Industrials

    $AMRZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amrize Partners with Chicago Architecture Biennial to Advance Building

    Amrize joins North America's largest architecture biennial Platform to exchange with architecture and design firms on materials science and innovation to advance how we build and live With operational headquarters in Chicago, Amrize delivers advanced building solutions for North America's most innovative projects Amrize (NYSE:AMRZ) announced today that it is partnering with the Chicago Architecture Biennial, North America's leading forum for modern architecture and design, to foster innovation in building design and construction. As a "Blueprint" partner, Amrize will join leading architecture and design firms, construction partners, public authorities and industry experts to excha

    9/23/25 11:00:00 AM ET
    $AMRZ
    Building Materials
    Industrials

    Amrize Recommends Shareholders Reject Mini-Tender Offer By TRC Capital Investment Corporation

    Amrize Ltd (NYSE:AMRZ) has received a notice of an unsolicited "mini-tender" offer by TRC Capital Investment Corporation ("TRC") to purchase up to 2,000,000 ordinary shares, $0.01 par value per share (the "Ordinary Shares") of Amrize at a price of $49.63 per Ordinary Share in cash.  The offer represents less than 1.0% of the outstanding Ordinary Shares.  TRC's offer price is 4.48% less than the $51.96 closing price per Ordinary Share on August 26, 2025, the last trading day before the mini-tender offer commenced. Amrize does not endorse TRC's unsolicited mini-tender offer and recommends that Amrize shareholders do not tender their Ordinary Shares in the offer because the offer is at a pri

    8/28/25 6:44:00 PM ET
    $AMRZ
    Building Materials
    Industrials

    Amrize Delivers Solid Second Quarter, Starts Journey in Position of Strength

    Successful spin-off and listing of Amrize on the NYSE and SIX on June 23 Resilient Q2 results with strong margins show strength of the business and market positions Launched ASPIRE program to drive $250M+ in synergies and accelerate margin expansion Investing for growth with CapEx and M&A; acquired operations of Langley Concrete Group, Inc. Established investment-grade balance sheet with substantial financial firepower Well positioned to capitalize on long-term, profitable growth within a $200B+ addressable market Amrize (AMRZ) announced today its second quarter 2025 financial results. Jan Jenisch, Chairman and CEO: "We successfully listed Amrize on the NYSE and SIX on

    8/6/25 4:15:00 PM ET
    $AMRZ
    Building Materials
    Industrials

    $AMRZ
    Financials

    Live finance-specific insights

    View All

    Amrize Announces Date for Second Quarter 2025 Financial Results

    Amrize (NYSE:AMRZ) will publish its second quarter 2025 financial results after the U.S. market closes on Wednesday, August 6, 2025, followed by a webcast to discuss the company's financial results at 9:00 am Eastern Time on Thursday, August 7, 2025. Registration for the Q2 2025 live webcast can be completed at https://amrize-quarterly-results-q2-2025.open-exchange.net/ Amrize's financial results, presentation materials and webcast will be accessible in the events section of www.amrize.com/investors. A replay and transcript will be available at the same location following the webcast. About Amrize Amrize (NYSE:AMRZ) is building North America, as the partner of choice for professiona

    7/21/25 2:00:00 PM ET
    $AMRZ
    Building Materials
    Industrials